SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wvalx who wrote (21036)4/21/1999 6:03:00 PM
From: Brent  Read Replies (1) of 23519
 
wvalx,

I have full confidence in AZ as well.

My point on signing a partner on unfavorable terms is that we could have signed a contract with a renegotiation clause after a year based on sales. It would have given us a presence in the US, increased sales, therefore decrease avg cost per piece. After a year of unfavorable terms, we could renegotiate more favorable terms.

What Lee is doing is like the star college player holding out a year because he wants a big contract. Get in there and play, you'll get the big contract after you prove your worth it.

Brent

BTW, I did see positives too, but many posts had already covered them.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News